30 closest matches · ranked by relevance
Surgical Technique
Primary: Intraoperative Duration — 22.5; 12.8 Min
Circumcision
Primary: Intraoperative Duration — 9.0; 22.6 Min
Circumcision
Primary: Intraoperative Duration — 22.6; 13.0; 25.0; 28.6 minutes
HIV Infections · Sexually Transmitted Infections
Primary: Number of Male Clients Who Will Undergo Circumcision (Uptake of VMMC) — 8; 25; 13; 17 Participants — p=0.044
Voluntary Medical Male Circumcision
Primary: Cumulative Percentage of Patients With an Adverse Event (AE) (Moderate or Severe) on or Before Day 14 Visit — 2.3; 1.01 percentage of participants
HIV Infections
Primary: Illicit Drug Use Days — 3.17; 3.10; 3.25; 2.86 Number of Days — p=0.35
HIV Infections · Sexually Transmitted Diseases
Primary: Any Unprotected Anal Intercourse (UAI) With Casual Partners — 2.0; 6.2 Number of episodes — p=< 0.05
Circumcision, Male
Primary: Time Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound Dressing — 12; 25 Minutes
Substance Use · Sexual Risk
Primary: Illicit Drug Use Days — 3.04; 11.62; 2.00; 6.04 days — p=.19
HIV · Pregnancy
Primary: Dried Blood Spot Analysis of Medication Adherence- Mother and Infant — 56; 157; 35; 183 Participants
HIV Infection
Primary: Number of Participants With Serum Creatinine Event of Grade 1 or Higher — 1 Participants
HIV
Primary: Actual Number of Study Visits Completed by 24 Weeks — 3.5927; 4.6263; 4.6374 Visits — p=0.6983
Male Circumcision
Primary: Time for Procedure — 9.0 Min
Human Immunodeficiency Virus
Primary: Number of Participants With Self-reported Self-administration of HIV Testing — 46; 44 Participants
Malaria
Primary: The Activity of Single Oral Doses of MMV533 (Name of Investigational Medicinal Product) on Clearance of Plasmodium — 42.17; 158.03; 187.57 PRR48=parasite reduction ratio…
Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
Primary: Treatment Completion — 15 Participants
Hiv
Primary: Number of Women Retained in Care — 160; 164 Participants
HIV
Primary: HIV Self-testing With Online Supervision Past 6 Months at Baseline — 50; 44 Participants
Sexual Behavior
Primary: Study Feasibility Based on the Overall Recruitment Rate — 36.5 overall recruitment rate
HIV
Primary: Retention in the Cohort — 88; 84; 87 Participants
HIV/AIDS · STD
Primary: Prevalence of HIV Testing in the Past 6 Months Among YMSM at Baseline — 92; 48 Participants
Human Papillomavirus
Primary: HPV Prevalence — 61 participants
HIV
Primary: Number of Women Who Came With Their Partners and Received Couple Counseling and Testing — 52; 70 Female participants receiving CHTC
HIV Infections
Primary: Number of Participants Reporting Local Reactogenicity Signs and Symptoms: Pain and/or Tenderness — 812; 794; 805; 1599 Participants
Human Immunodeficiency Virus Infection · Sexually Transmitted Diseases
Primary: Self-reported Consistent Condom Use During Vaginal Intercourse in the Past 3 Months — 121; 103; 125; 93 Participants — p=.008
Human Immunodeficiency Virus · Virus Shedding
Primary: Semen Clearance (CL) of Tenofovir — 33.88; 51.21; 5.65 L/hr
Malaria
Primary: Number of Participants With Adverse Events — 4; 5; 5; 6 Participants
Vaccination
Primary: ELISA Seropositivity Rate — 40.9; 100.0 percentage of subjects
Circumcision, Male
Primary: Neonatal Salivary Cortisol Level — 0.63; 0.72; 1.14; 1.08 mcg/dL
HIV Infections · Sexually Transmitted Diseases · Sexual Behavior
Primary: Confidence to Engage in HIV Prevention Behaviors When Engaging in Receptive Anal Sex Over Time — 1.72; 1.71; 1.73; 1.72 units on a scale